Springe direkt zu Inhalt

Structural requirements of mono- and multivalent L-selectin blocking aptamers for enhanced receptor inhibition in vitro and in vivo

Sebastian B. Riese, Konrad Buscher, Sven Enders, Christian Kuehne, Rudolf Tauber, and Jens Dernedde – 2016

L-selectin mediates extravasation of leukocytes from blood into the surrounding tissue during inflammation and is therefore a therapeutical target in certain overwhelming immune reactions. In this study, we characterized an L-selectin specific blocking DNA aptamer with respect to nucleotide composition and target binding. Introduction of deletions and nucleotide exchanges resulted in an optimized DNA sequence but preservation of the IC50 in the low nanomolar range. The inhibitory potential was significantly increased when the aptamer was displayed as a di- and trimer connected via appropriate linker length. Similar to monoclonal antibodies, trimer yielded picomolar IC50 values in a competitive binding assay. In comparison to the monovalent aptamer, the trivalent assembly reduced PBMC interactions to L-selectin ligands 90-fold under shear and exerted superior inhibition of PBMC rolling in vivo. In conclusion, our work demonstrates the feasibility of optimizing aptamer sequences and shows that multivalent ligand presentation enables superior adhesion receptor targeting.

Titel
Structural requirements of mono- and multivalent L-selectin blocking aptamers for enhanced receptor inhibition in vitro and in vivo
Verfasser
Sebastian B. Riese, Konrad Buscher, Sven Enders, Christian Kuehne, Rudolf Tauber, and Jens Dernedde
Datum
2016
Kennung
10.1016/j.nano.2015.12.379
Zitierweise
Nanomedicine 2016, 12 (4), 901–908
Art
Text
dfg_logo